Intrinsic Value of S&P & Nasdaq Contact Us

Longeveron Inc. LGVN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+792.9%

Stock Statistics — LGVN

Longeveron Inc. (LGVN) has a market capitalization of $26.1M and trades at $1.12. The 52-week range is 0.475-1.83.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.9, Earnings Per Share (EPS) of $-1.29, annual revenue of $1.2M.

The stock has a beta of -0.19, operates in the Healthcare sector.

Trading Data
Current Price$1.12
52-Week Range0.475-1.83
Volume772.88K
Avg Volume (30D)5.69M
Market Cap$26.1M
Beta (1Y)-0.19
Company
IPO Date2021-02-12
Employees25
CEOStephen H. Willard
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS54303L2034
CUSIP54303L104
Income (Latest Year)
Revenue$1.2M
Gross Profit$803K
EBITDA$-22.06M
Operating Income$-23.29M
Net Income$-22.7M
EPS$-1.29
EPS Diluted$-1.29
Shares Outstanding$17.58M
Balance Sheet (Latest Year)
Total Assets$10.26M
Current Assets$5.45M
Cash & ST Investments$4.66M
Total Liabilities$4.59M
Total Debt$824K
Net Debt$-3.84M
Total Equity$5.68M
Debt / Equity0.15
Valuation Ratios
P/E Ratio-0.9
P/S Ratio21.77
P/B Ratio4.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message